CUVClinuvel PharmaceuticalsCUV info
$10.13info-1.19%24h
Global rank11332
Market cap$500.75M
Change 7d-
YTD Performance-6.43%
SP500 benchmarkUnderperform
P/E17.15
P/S9.45
Revenue$52.99M
Earnings$20.71M
Dividend yield-
Main Sector
Healthcare

EPS for Clinuvel Pharmaceuticals (CUV)

Clinuvel Pharmaceuticals has an EPS of $0.591. In 2022, the company made an earnings per share (EPS) of $0.403. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.

EPS for CUV

-
Value:-

EPS history for Clinuvel Pharmaceuticals from 2001 to 2023

YearEPSChange
2023$0.59146.65%
2022$0.403-16.74%
2021$0.48446.67%
2020$0.33-

View the highest EPS stocks

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org